The FDA announced on 2019-08-08 that Alkermes Inc. is recalling Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial kits due to labeling errors involving incorrect needle placement. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Alkermes
- Product: Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial
- Kit NDC: 65757-300-01
- Lot code: 2018-3010T
- Expiration date: 8/2021
- Quantity: 6,514 kits
The hazard
The drug product kit was recalled because 1-inch needles were placed in the 1 1/2-inch needle cardboard sleeve labeled as administration needles. The record states that the product vial is not impacted.
Context
GovInfoNow's records show Alkermes, Inc. has three other recalls on record since 2012-11-06. Other recent recalls of similar products include Meitheal Cetrorelix Acetate Injection Kit Recall (2026-02-09), Winder Morphine Sulfate Oral Solution Recall (2025-11-26), and Lupin Liraglutide 18mg/3mL Injection Recall (2026-04-24).